Drug intelligence / Profile preview

tetracosactide hexaacetate

Development stage
Approved
Lead developer
Mallinckrodt
Modality
Peptides, Small Molecules
Administration
Intramuscular, Intravenous, Infusion (intravenous)
01

Overview

**Tetracosactide hexaacetate** is a synthetic peptide analog of adrenocorticotropic hormone (ACTH), corresponding to the first 24 amino acids of natural ACTH (1-24 fragment), in the form of its hexaacetate salt. It acts as a potent agonist at the ACTH (melanocortin 2) receptor in the adrenal cortex, stimulating the synthesis and release of corticosteroids, including glucocorticoids, mineralocorticoids, and to a lesser extent, androgens. It is used primarily as a **diagnostic agent** for the assessment of adrenocortical insufficiency and, in some settings, for short-term therapeutic use where stimulation of endogenous corticosteroid production is desired (e.g., exacerbations of multiple sclerosis, certain rheumatic, neurological, and skin diseases, and infantile spasms/West syndrome). Unlike corticosteroid drugs, it induces a physiological spectrum of corticosteroids. The hexaacetate form offers improved stability and controlled-release pharmacokinetics for injectable use[1][3][5][7][8].

Brand names
SynacthenSynacthen DepotCortrosyn
Other names
tetracosactrintetracosactidacorticotropin-(1-24)adrenocorticotropic hormone fragment 1-24 human, rat
02

Targets

MC2R (Adrenocorticotropic Hormone Receptor)MC4R (Melanocortin 4 receptor)

Beyond the preview

Go deeper on tetracosactide hexaacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetracosactide hexaacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call